Kyndryl KD 深 沪
已收盘 11-06 16:00:00 美东时间
16.29
+0.110
+0.68%
华盛通- 最 高16.55
- 今 开15.83
- 成交量 511.99万股
- 最 低 15.27
- 昨 收 16.18
- 总市值 35.48亿
- 52周最高 27.835
- 市盈率 静 19.23
- 换手率 2.35%
- 52周最低 10.10
- 委 比 -50.00%
- 总股本 2.18亿
- 历史最高 44.20
- 量 比 0.74
- 振 幅 7.91%
- 历史最低 7.93
- 每 手 1
- 风险率 5.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 可口可乐、麦当劳、3M等获多家大行看好；机构上调高通目标价至165美元
今日重点评级关注：Citizens：维持Precigen"跑赢大市"评级，目标价从11美元升至12美元；Leerink Partners：维持Arcus Biosciences"跑赢大市"评级，目标价从46美元升至49美元
11-06 16:15
Susquehanna Maintains Neutral on Kyndryl Holdings, Raises Price Target to $16
Susquehanna analyst James Friedman maintains Kyndryl Holdings (NYSE:KD) with a Neutral and raises the price target from $13 to $16.
11-05 21:37
美股前瞻 | 中选靴子落地！华尔街集体看多美股；硬件股颓势依旧！闪迪跌逾6%，机构激辩AI股是否已超卖
中选靴子落地！华尔街集体看多美股；硬件股颓势依旧！闪迪跌逾6%，美光跌逾4%，机构激辩AI股是否已超卖；花旗看涨黄金至5000美元，AAOI、IREN盘后放榜>>
11-05 21:24
美股牛股 | 业绩股集体大涨！Kyndryl飙升30.1%、多邻国涨26%；Medline升18.4%，宣布10亿美元股票回购计划
美股牛股 | 业绩股集体大涨！Kyndryl飙升30.1%、多邻国涨26%；Medline升18.4%，宣布10亿美元股票回购计划
11-05 13:50
财报速睇 | Kyndryl 2026财年Q3营收36.51亿美元，同比下降1.9%；归母净利润0.59亿美元，同比下滑13.2%
华盛资讯11月5日讯，Kyndryl公布2026财年Q3业绩，公司Q3营收36.51亿美元，同比下降1.9%，归母净利润0.59亿美元，同比下滑13.2%。
11-05 09:31
Kyndryl shares are trading higher after the company reported better-than-expected Q2 financial results and reaffirmed its FY2027 sales guidance.
Kyndryl shares are trading higher after the company reported better-than-expected Q2 financial results and reaffirmed its FY2027 sales guidance.
11-04 23:25
Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones gaining around 1,100 points on Wednesday. Shares of Wayfair Inc (NYSE:W) rose sharply after the company reported better-than-expected quarterly financial results. Wayfair reported adjusted earnings of 93 cents per share, beating the analyst consensus estim...
11-04 23:02
财报速睇 | Kyndryl 2026财年Q3营收36.51亿美元，同比下降1.9%；归母净利润0.59亿美元，同比下滑13.2%
华盛资讯11月4日讯，Kyndryl公布2026财年Q3业绩，公司Q3营收36.51亿美元，同比下降1.9%，归母净利润0.59亿美元，同比下滑13.2%。
11-04 20:33
Kyndryl Hldgs Affirms FY2027 Sales Guidance of $14.790B-$15.092B vs $14.799B Est
Kyndryl Hldgs (NYSE:KD) affirms FY2027 sales outlook from $14.790 billion-$15.092 billion to $14.790 billion-$15.092 billion vs $14.799 billion estimate.
11-04 20:08
Kyndryl Announces It Accepts Dutch Ministry Of Economic Affairs And Climate Policy Decision To Prohibit Co. From Its Proposed Acquisition Of Solvinity
https://www.kyndryl.com/us/en/about-us/news/2026/10/statement-solvinity-netherlands
10-14 01:28
